Concepedia

Author

Victor K. Phuong

Johnson & Johnson (United States)

Also Known As

Phuong, V.K., Victor K Phuong, Victor K. Phuong

12

Publications

198

Citations

7

H-Index

16

Concepts

All Affiliations

Johnson & Johnson (United States)
VK

About

Victor K. Phuong is an author at Johnson & Johnson (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

179

2

Biochemistry

3

3

125

3

Natural Sciences

2

2

75

4

Cell Biology

1

1

40

5

Chemical Biology

1

1

35

Victor K. Phuong

×

5

Publications

179

Citations

5

H-Index

YearCitations

Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX2R) antagonists

Laura C. McAtee, Steven W. Sutton, Dale A. Rudolph,

Bioorganic & Medicinal Chemistry Letters

2004

78

Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2α (HRI) kinase

Mark D. Rosen, Craig R. Woods, Steven D. Goldberg,

Bioorganic & Medicinal Chemistry Letters

2009

40

Identification and Optimization of Anthranilic Sulfonamides as Novel, Selective Cholecystokinin-2 Receptor Antagonists

Brett D. Allison, Victor K. Phuong, Laura C. McAtee,

Journal of Medicinal Chemistry

2006

35

Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists II: Tuning of receptor selectivity and in vivo efficacy

Marna Pippel, Kristen Boyce, Hariharan Venkatesan,

Bioorganic & Medicinal Chemistry Letters

2009

14

Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: Discovery of CCKR1 selectivity in a previously CCKR2-selective lead series

Marna Pippel, Brett D. Allison, Victor K. Phuong,

Bioorganic & Medicinal Chemistry Letters

2009

12

Page 1